White Paper - Skin Health Industry in 2020: Changes Driving Investment Opportunities
As 2020 draws to a close, we reflected upon what has been a truly extraordinary year. Faced with adversity, the healthcare industry quickly adapted and innovated, accelerating the adoption of tools and technologies to ensure continued delivery of high-quality patient care.
As of this writing, COVID-19 vaccines have begun their roll-out. The speed at which these vaccines were developed, tested, and authorized is truly astonishing and a testament to the capabilities of the healthcare industry, with the right resources, to meet the needs of humanity.
While 2020 has been a year of ups and downs, we believe the skin health industry has emerged stronger and more eager to innovate to meet the evolving needs of society. We are optimistic for the future ahead.
In our latest paper we reflect on select key developments and trends from this past year that will be defining the skin health industry for years to come. Topics we discuss include the impact of COVID-19 on clinicians and dermatology practices, the increased incidence of skin diseases and conditions and the subsequent impact on overall health, and the effect video conferencing has had on the aesthetics industry.
Prior to 2020 and the COVID-19 global pandemic, there existed is a myriad of evolving factors – demographic, socioeconomic, environmental, among others – that demanded innovation for skin health. 2020 not only underscored that these factors continue to be highly relevant, but emphasized the urgency for new innovations that can enhance diagnostic capabilities, empower physicians to provide better patient care, increase access to care, and improve patient outcomes.
As 2021 draws near, we are encouraged by the resilience of skin health industry and are enthusiastic for what’s to come.